Search research articles
Contact Us
Filters
Showing results (131-140 of 282) with videos related to
Page
of 29
Sort By:
Journal of Neurovirology
|
March 16, 2018
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39)
Arkaitz Imaz, Jordi Niubó, Alieu Amara, et al.
The Journal of Infection
|
February 21, 2023
The association of epicardial adipose tissue volume and density with coronary calcium in HIV-positive and HIV-negative patients
Thomas Heseltine, Elen Hughes, Jean Mattew, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 6, 2023
Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma
Elizabeth Challenger, Sujan Dilly Penchala, Colin Hale, et al.
AIDS Research and Therapy
|
June 7, 2022
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Perez Nicholas Ochanda, Mohammed Lamorde, Kenneth Kintu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 13, 2016
The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma
Sujan Dilly Penchala, Sandra Fawcett, Laura Else, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
April 23, 2024
A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells
Elizabeth Challenger, Sujan Dilly-Penchala, Colin Hale, et al.
The Journal of Antimicrobial Chemotherapy
|
June 18, 2011
Ageing with HIV: medication use and risk for potential drug-drug interactions
Catia Marzolini, David Back, Rainer Weber, et al.
AIDS (London, England)
|
December 2, 2024
Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV
Anna Jane Dreyer, Celine Le Roux, Kevin G F Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 20, 2011
Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals
Akil Jackson, Victoria Watson, David Back, et al.
The Journal of Antimicrobial Chemotherapy
|
July 16, 2004
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen
Adil Isaac, Stephen Taylor, Patricia Cane, et al.
Page
of 29
Search research articles
Search
Showing results (131-140 of 282) with videos related to
Sort By:
Page
of 29
Journal of Neurovirology
|
March 16, 2018
Cerebrospinal fluid drug concentrations and viral suppression in HIV-1-infected patients receiving ritonavir-boosted atazanavir plus lamivudine dual antiretroviral therapy (Spanish HIV/AIDS Research Network, PreEC/RIS 39)
Arkaitz Imaz, Jordi Niubó, Alieu Amara, et al.
The Journal of Infection
|
February 21, 2023
The association of epicardial adipose tissue volume and density with coronary calcium in HIV-positive and HIV-negative patients
Thomas Heseltine, Elen Hughes, Jean Mattew, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 6, 2023
Development and validation of an LC-MS/MS method for quantification of favipiravir in human plasma
Elizabeth Challenger, Sujan Dilly Penchala, Colin Hale, et al.
AIDS Research and Therapy
|
June 7, 2022
A randomized comparison of health-related quality of life outcomes of dolutegravir versus efavirenz-based antiretroviral treatment initiated in the third trimester of pregnancy
Perez Nicholas Ochanda, Mohammed Lamorde, Kenneth Kintu, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
June 13, 2016
The development and application of a novel LC-MS/MS method for the measurement of Dolutegravir, Elvitegravir and Cobicistat in human plasma
Sujan Dilly Penchala, Sandra Fawcett, Laura Else, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
April 23, 2024
A novel LC-MS/MS method for the determination of favipiravir ribofuranosyl-5'-triphosphate (T-705-RTP) in human peripheral mononuclear cells
Elizabeth Challenger, Sujan Dilly-Penchala, Colin Hale, et al.
The Journal of Antimicrobial Chemotherapy
|
June 18, 2011
Ageing with HIV: medication use and risk for potential drug-drug interactions
Catia Marzolini, David Back, Rainer Weber, et al.
AIDS (London, England)
|
December 2, 2024
Psychosocial factors account for a proportion of the difference in cognitive performance between persons with and without HIV
Anna Jane Dreyer, Celine Le Roux, Kevin G F Thomas, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
September 20, 2011
Plasma and intracellular pharmacokinetics of darunavir/ritonavir once daily and raltegravir once and twice daily in HIV-infected individuals
Akil Jackson, Victoria Watson, David Back, et al.
The Journal of Antimicrobial Chemotherapy
|
July 16, 2004
Lopinavir/ritonavir combined with twice-daily 400 mg indinavir: pharmacokinetics and pharmacodynamics in blood, CSF and semen
Adil Isaac, Stephen Taylor, Patricia Cane, et al.
Page
of 29